Phase 2 Readout~quarter

Phase 2 Readout: tyra-300

Indication
low-grade, intermediate risk non-muscle invasive bladder cancer (IR NMIBC)

Other upcoming events for TYRA

Phase 2 ReadoutPhase 2 Readout: tyra-300
Phase 2 ReadoutPhase 2 Readout: dabogratinib
Phase 2 ReadoutPhase 2 Readout: dabogratinib

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Readout: tyra-300 — TYRA Phase 2 Readout | BioSniper